Pharmaceuticals

Pliant Therapeutics

RBC Capital Analyst Maintains 'Hold' Rating on Pliant Therapeutics

Pliant Therapeutics released FY2025 9 Months earnings on November 6 (EST), actual revenue USD 0, actual EPS USD -2.051

Pliant Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4299 (forecast USD -0.5233)

Pliant Therapeutics released FY2025 Semi-Annual Earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -1.6224

Pliant Therapeutics released FY2025 Q2 earnings on August 7, 2025 (EST), with actual revenue USD 0 (forecast USD 0) and actual EPS USD -0.7053 (forecast USD -0.7338)

Pliant Therapeutics updates BEACON-IPF trial

Pliant Therapeutics Stops IPF Drug Development

Pliant Implements Cost-Cutting Measures to Support Late-Stage Clinical Trials

Pliant Cutting Costs to Prepare for Later-Stage Clinical Trials

Pliant cuts costs to advance late-stage clinical trials

Pliant Implements Cost Reduction Strategies

Pliant Therapeutics Displays Bexotegrast Data and Receives FDA, EMA Approvals

Pliant Implements Cost Cutting Measures

Pliant Implements Cost-Cutting Measures for Advancing Clinical Trials

Pliant Implements Cost-saving Measures for Late-stage Clinical Trials

Pliant Implements Cost-Cutting Strategies for Late-Stage Clinical Trials

Pliant Tightens Cost Cutting Measures for Advanced Clinical Trials

Pliant Therapeutics released FY2025 Q1 earnings on May 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.9174 (forecast USD -0.7354)

Pliant Therapeutics Reports Increased Q1 2025 Loss and Announces Strategic Restructuring

Pliant Therapeutics Inc reports Q1 EPS loss of 72 cents

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap